1. Human Research Protection Program Training: Preparing an Expedited or Exempt Application December 12, 2007 Lisa Voss, MPH, CIP Policy Analyst Human Research Protection Program Lisa.Voss@ucsf.edu 514-2152 Joanne Mickalian, MS Assessment Team Human Research Protection Program Joanne.Mickalian@ucsf.edu 476-1744

2. 12/12/07 Outline for Today Intro to HRPP (CHR and QIU) organization, applications, and review process Preparing Expedited and Exempt Applications Common errors and Tips Q&A

5. First step: Determining – “Is the project human subject research?”

6. 12/12/07 Definition of Research A systematic investigation, including research development, testing and evaluation designed to develop or contribute to generalizable knowledge. (45 CFR 46.102)

7. 12/12/07 Definition of Human Subject A living individual about whom an investigator (whether professional or student) conducting research obtains data through intervention or interaction with the individual, or identifiable private information. (DHHS 45CFR46.102)

8. 12/12/07 When is it NOT a Human Subject If the Investigator obtains coded data or biological samples under the following conditions: The coded private information or specimens cannot be collected specifically for the current proposed research project, and one or more of the following apply:

9. 12/12/07 Conditions The key to decipher the code is destroyed before the researcher begins, or The PI and holder of the key enter into an agreement prohibiting the release of the key under any circumstance (The CHR recommends a written agreement be secured between the recipient and the provider of the specimens or data. The CHR will not require review of these agreements.), or There are IRB-approved written policies for the repository or data management that prohibit the release of the key.

12. Second step: Determining the Level of Review/Type of Application to Submit

13. 12/12/07 Review Level Based on Risk to the Subject The level of risk to the subject determines the level of review required and therefore the type of application. The risk level is compared to “minimal risk” as defined by federal regulation. “Minimal risk” means the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examination or tests” (45CFR46.102).

14. 12/12/07 CHR Levels of Review/Applications Greater than minimal risk: Full Committee Less than minimal risk: Expedited Review (Category 1-4, 6,7) Expedited Review: No Subject Contact (Category 5) Exempt (Category 1, 2, 3) Exempt (Category 4) Not Human Subjects Self-Certification Form

15. 12/12/07 Expedited Review Categories 1. Research with approved drugs/devices 2. Blood sampling (small amounts) 3. Noninvasive specimen collection 4. Noninvasive clinical procedure 5. Use of data or specimens collected for nonresearch purposes

16. 12/12/07 Expedited Review Categories 6. Research recordings (voice, video, digital, or image recordings) 7. Low risk behavioral research 8. Renewal of inactive research protocols or protocols that are essentially complete 9. Renewal of other minimal risk research protocols

17. 12/12/07 Exempt Review Categories 1. Research conducted in established or commonly accepted educational settings. 2. Research involving the use of educational tests, survey procedures, interview procedures, or observations of public behavior if they are anonymous or disclosure of individuals identity does not put them at risk. DOES NOT APPLY to research with UCSF patients, children (minors), and prisoners 3. Interviews or surveys with public officials

18. 12/12/07 Exempt Review Categories 4. Research involving the collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available or if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects. Important Note: Exempt Categories involve human subjects.

19. Third step: Expedited Review Filling out the Expedited Review Application and Supplements

20. 12/12/07 Expedited Review Application Part 1: Administrative Requirements PI, Co-PI, Contact Person Study sites Funding Scientific Merit Key Personnel Financial Interests PI Signature

21. 12/12/07 Expedited Review Application Part 2: Study Design Synopsis vs. Design vs. Procedures Hypotheses Specific Aims Background vs. Preliminary Studies Design Statistical Analysis Sample Size

22. 12/12/07 Expedited Review Application Part 3: Procedures Clear description of research procedures. What is the subject being asked to do for the purpose of the research study How does this compare or what is the subject being asked to do in addition to their normal standard of care Written in a way that can be replicated and understood by someone not in your field Tables, charts, or flow-diagrams may help explain the process and timeline

23. 12/12/07 Expedited Review Application Part 4: Alternatives Provide a discussion of the alternatives to participation. Many times includes not participating!

24. 12/12/07 Expedited Review Application Part 5: Risks and Benefits Risks and Discomforts Description of risks Physical risk of blood draw to emotional risk of asking questions Steps to minimize risks Providing an opportunity for questions, follow recommended recruitment guidelines Maintaining confidentiality - data Maintaining privacy - individuals

25. 12/12/07 Expedited Review Application Part 5: Risks and Benefits HIPAA section Identify source and personal health information that will be collected How maintained and protected Disclosures Benefits – Overall risk/benefit analysis Explanation of why the benefit outweighs the risk of loss of confidentiality

26. 12/12/07 Expedited Review Application Part 6: Subject Information CHR Supplements? Inclusion & Exclusion Criteria Be Specific Determining eligibility Non-regulated vulnerable populations

27. 12/12/07 Expedited Review Application Part 7: Recruitment How, when, where and by whom are potential subjects approached Respect for privacy Lack of pressure Unbiased presentation Who conducts initial contact? Written so that it can be understood by a reviewer that is not in your scientific field or works in your Department

28. 12/12/07 Expedited Review Application Part 8: Informed Consent How, where, when and by whom informed will be obtained Ensuring Understanding Consent Signed consent Waiver of signed consent Waiver of consent

29. 12/12/07 Expedited Review Application Part 9: Financial Considerations Will there be reimbursement for subjects? How will they be paid, check, cash, gift card? Is the amount coercive? Will subjects have to pay for any costs associated with the study?

30. 12/12/07 Expedited Review Application Part 10: Bibliography Part 11: Attachments Bibliography Provide a comprehensive list of references as it pertains to your application Attachments Sponsors protocol Survey instruments Recruitments and advertisement materials Consent forms

31. 12/12/07 CHR Application Supplements: Full Committee and Expedited Only Inclusion of Children and Minors Human Biologic Specimen Collecting and/or Banking for Future Research Waiver of Informed Consent/Authorization for Minimal Risk Research or Screening Disclosure of Investigators’ Financial Conflict of Interest IRB Approval Certification for UCSF Researchers Involving Non-UCSF Affiliated Sites More on HRPP website

32. 12/12/07 Expedited Review Application: No Subject Contact Differences form main applications Procedure section (Part 3) Biological specimen or data analysis (involves identifiers) Identify source and how collected Consent section (Part 6) Waiver of consent/authorization Does not include Alternatives, recruitment, payment and cost sections

33. Third step: Exempt Certification Filling out the Exempt Certification Application

34. 12/12/07 Exempt Certification Application Part 1: Administrative Requirements PI, Co-PI, Contact Person Study sites Funding Key Personnel Financial Interests PI Signature

35. 12/12/07 Exempt Certification Application (Category 1, 2, 3) Part 2: Study Specific Information Study purpose and design Describe human research subject population How human research subjects will be contacted Study instruments (surveys, questionnaires) How inform subjects of research study– consent regulations do not apply to Exempt research but UCSF requires some form of information sheet. See Exempt Guidance on HRPP website. How information obtained will be recorded and maintained PI Signature

36. 12/12/07 Exempt Certification Application (Category 4) Part 2: Study Specific Information Briefly describe study activities Identify source of biological specimens and/or data Must be pre-existing at time of proposed research Can have access to identifiers if information is publicly available or information is recorded in a way that the biological specimen or data can be identified, directly or through identifiers linked to the subjects. DOES NOT APPLY to research medical records

37. Fourth step: Consent Preparing a consent form, assent form, information sheet, or requesting waiver of consent

38. 12/12/07 Three types of consent Signed consent consent forms, parental consent forms, assent forms Waiver of signed consent Information sheet or verbal script Waiver of consent Waiver of Informed Consent/Authorization for Minimal Risk Research or Screening Supplement

39. Fifth step: Review Process

40. 12/12/07 Review Process Expedited and Exempt Applications  Assessment/screening   Review by IRB member(s) or Chair  Post review correspondence   Approval

41. 12/12/07 What do CHR members consider when reviewing a new study? Risks to subjects are minimized Procedures are consistent with sound research design and do not unnecessarily expose subjects to risk. Study utilizes procedures already performed for diagnosis/treatment Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects and the importance of the knowledge that may reasonably be expected to result Selection of subjects is equitable Inclusion/exclusion criteria are adequate Research purpose and setting is appropriate Recruitment process is fair

42. Top Tips and Additional Discussion Points

43. 12/12/07 Top Tips for Speeding Up Your CHR Approval Make sure science is sound. Study should be reviewed for scientific merit, preferably by a group of peers, before submitting to the CHR. Determine appropriate level of review, or if review is required.appropriate level of review

44. 12/12/07 Top Tips for Speeding Up Your CHR Approval Download and follow the most current CHR Application Forms and Consent Templates from HRPP website. Click on links in application for help. Check the HRPP website to see which Application Supplements are needed for your particular study.

45. 12/12/07 Top Tips for Speeding Up Your CHR Approval Consider the audience when writing application and consent documents: Avoid acronyms if possible; if needed, spell out before first use. Write application with understanding that not all members are scientists, and few if any are experts in your field. Consent documents should be written in lay language at a grammatical level appropriate for the prospective subjects. Avoid jargon, legalese, long complex sentences, and use of passive voice.

46. 12/12/07 Top Tips for Speeding Up Your CHR Approval Strive for consistency within and among the various parts of the submission: Assure that all sections within the CHR Application are consistent with each other, i.e., the purpose, benefits and alternatives. Assure that all sections within the consent form are consistent (see above). Assure that the protocol and consent form are consistent. Use the same name for the subject groups throughout the application and consent documents.

47. 12/12/07 Top Tips for Speeding Up Your CHR Approval Provide a detailed discussion of the recruitment and consent process. Include the who, what, when, where and how of each. Submit copies of all recruitment materials and consent documents, including scripts.

48. 12/12/07 Top Tips for Speeding Up Your CHR Approval Write a cover letter to explain and highlight any particularly difficult or sensitive issues to show that you have thought them through ahead of time, or ask for CHR input, or inform the CHR if you have special time constraints, i.e., if study is being sent in “just in time” for NIH funding, you have a patient waiting. Explain how many consent forms are being used if there are several – this is particularly important for research involving minors.

49. 12/12/07 Top Tips for Speeding Up Your CHR Approval Proofread Your Work!!!!! Do a final review of CHR Application and study documents. If you are preparing the application and are not the study PI, make sure the study PI has read the application. This is critical if the PI is your mentor.

50. 12/12/07 Top Tips for Speeding Up Your CHR Approval If you have any questions about the process, call the CHR office at 476-1814 and ask to speak to the Analyst of the Day or e-mail chr@ucsf.edu. Calls and e-mails will be returned within 24 hours. Bonus Tip: Get a separate CHR approval for each discrete study. Do not group related studies into a complicated application

51. 12/12/07 Ask Questions Ask your PI or Mentor Call or email the CHR and ask for Analyst of the Day Main Line: 415-476-1814 http://www.research.ucsf.edu/chr/

53. 12/12/07 Topics from Survey Request Modifications and Renewals Certificates of Confidentiality Research vs. Quality Improvement Writing Consent Forms and Informed Consent Process HIPAA AE’s, Violations and Incidents

54. 12/12/07 HRPP Training: Upcoming sessions Preparing Consent and Assent Forms February 2008 Richard Wagner, HRPP Associate Director After CHR Approval: Post Approval Event Reporting April 2008 HRPP QIU Program

55. 12/12/07 More Resources CTSI: Clinical and Translational Science Institute http://ctsi.ucsf.edu/ RKS: Regulatory Knowledge and Support http://ctsi.ucsf.edu/rks/request/ Marlene Berro Marlene.Berro@ucsf.eduMarlene.Berro@ucsf.edu, 476-3426 BREAD: Biostatistics, Research Ethics And Design Program CtsiBread@ucsfmedctr.org, 502-7893 CtsiBread@ucsfmedctr.org